Literature DB >> 3872407

Capsular variation in experimental strains of Haemophilus influenzae.

P S Huber, I N Egwu.   

Abstract

This study sought to demonstrate that clinically untypable strains of Haemophilus influenzae are derivable from previously capsulated ones. Penicillin-induced forms were employed to explore in vivo and in vitro a possible mechanism of the reversible cycle vegetative to L-phase revertant. Normal H. influenzae type b (Rab), capsule-deficient strain ATCC 9333, and experimental L-phase and its revertants were used in this investigation. Capsular antigens, polyribose phosphate (PRP) content of each strain was assayed by orcinol and rocket immunoelectrophoretic methods. Intra- and inter-strain PRP differences were statistically analysed. Strain differences between in vivo and in vitro passaged extracts of strain 9333 and 9333 were significant (t-test P less than 0.01). There were also significant differences in vivo and in vitro between penicillin-treated, L-phase infected mouse isolates and penicillin-free, L-phase infected mouse isolates; and also between penicillin-treated, L-phase infected mouse isolates and revertant Rab infected mouse isolates (Mann-Whitney U-test P less than 0.02, P less than 0.01, respectively). These findings suggest that untypable isolates of H. influenzae are derivable from otherwise capsulated strains, depending on decapsulating factors in the microenvironment. Clinical implications of the findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872407     DOI: 10.1007/bf02125038

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  20 in total

1.  Osmotically stable L forms of Haemophilus influenzae and their significance in testing sensitivity to penicillins.

Authors:  J R May; D E Roberts; A Ingold; S V Want
Journal:  J Clin Pathol       Date:  1974-07       Impact factor: 3.411

2.  New methods in the study of bacterial L-forms and Mycoplasma.

Authors:  I N Egwu
Journal:  Health Lab Sci       Date:  1973-01

3.  Serotyping of noncapsular Haemophilus influenzae.

Authors:  J B Kirkman; J J Crawford
Journal:  Appl Microbiol       Date:  1971-07

4.  [Study of a stable strain of Brucella melitensis spheroplasts (L forms)].

Authors:  J Roux; J Sassine
Journal:  Ann Inst Pasteur (Paris)       Date:  1971-02

5.  The immune response to acute otitis media in children. II. Serum and middle ear fluid antibody in otitis media due to Haemophilus influenza.

Authors:  J L Sloyer; C C Cate; V M Howie; J H Ploussard; R B Johnston
Journal:  J Infect Dis       Date:  1975-12       Impact factor: 5.226

6.  Haemophilus influenzae in cultures of cerebrospinal fluid. Noncapsulated variants typable by immunofluorescence.

Authors:  B W Catlin
Journal:  Am J Dis Child       Date:  1970-09

7.  Identification and quantitation of capsular antigen in capsulated and noncapsulated strains of Haemophilus influenzae type b by crossed-immunoelectrophoresis.

Authors:  F L Buckmire
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

8.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

9.  Enzyme-linked immunosorbent assay for detection of Haemophilus influenzae type b antigen.

Authors:  B L Wetherall; P G Hallsworth; P J McDonald
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

10.  Methods for serotyping nasopharyngeal isolates of Haemophilus influenzae: slide agglutination, Quellung reaction, countercurrent immunoelectrophoresis, latex agglutination, and antiserum agar.

Authors:  D L Ingram; A M Collier; E Pendergrass; S H King
Journal:  J Clin Microbiol       Date:  1979-05       Impact factor: 5.948

View more
  1 in total

1.  Genetic relationships of serologically nontypable and serotype b strains of Haemophilus influenzae.

Authors:  J M Musser; S J Barenkamp; D M Granoff; R K Selander
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.